The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis
Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N
Record ID 32007000896
English
Authors' recommendations:
Study found that 12 months of treatment with clopidogrel seems to be cost-effective in both 'average' patients and higher-risk patients, while for lower-risk patients, treatment beyond 3 months does not appear to be cost-effective
Details
Project Status:
Completed
URL for project:
http://hta.ac.uk/1630
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Adolescent
- Adult
- Aged
- Drug Therapy, Combination
- Female
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Time Factors
- Treatment Outcome
- Withholding Treatment
- Young Adult
- Acute Coronary Syndrome
- Aspirin
- Platelet Aggregation Inhibitors
- Ticlopidine
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.